We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$43.2B
AUM Growth
+$3.45B
Cap. Flow
-$28.2M
Cap. Flow %
-0.07%
Top 10 Hldgs %
24.56%
Holding
1,434
New
145
Increased
810
Reduced
388
Closed
61

Top Buys

Rank Stock Value
1
NEM icon
Newmont
NEM
+$128M
2
MELI icon
Mercado Libre
MELI
+$109M
3
VEEV icon
Veeva Systems
VEEV
+$106M
4
DIS icon
Walt Disney
DIS
+$101M
5
B
Barrick Mining
B
+$97M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$315M
2
TSM icon
TSMC
TSM
+$277M
3
PFE icon
Pfizer
PFE
+$123M
4
SLB icon
SLB Ltd
SLB
+$115M
5
TMO icon
Thermo Fisher Scientific
TMO
+$108M

Sector Composition

Rank Sector Weight
1 Materials 36.19%
2 Technology 25.54%
3 Energy 6.85%
4 Healthcare 6.52%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
276
Novo Nordisk
NVO
$208B
$17.5M 0.04%
312,296
-17,776
-5% -$963K
BXMT icon
277
Blackstone Mortgage Trust
BXMT
$2.45B
$17.1M 0.04%
557,622
+71,363
+15% +$2.27M
NIO icon
278
NIO
NIO
$12.2B
$16.9M 0.04%
533,684
+58,611
+12% +$2.15M
BNY
279
Bank of New York Mellon
BNY
$106B
$16.9M 0.04%
291,020
+274,411
+1,652% +$15.8M
NVAX icon
280
Novavax
NVAX
$1.2B
$16.9M 0.04%
118,026
+1,101
+0.9% +$189K
ALNY icon
281
Alnylam Pharmaceuticals
ALNY
$27.5B
$16.7M 0.04%
98,614
+5,913
+6% +$1.1M
GSK icon
282
GSK
GSK
$104B
$16.5M 0.04%
298,739
+3,433
+1% +$179K
YUM icon
283
Yum! Brands
YUM
$41.8B
$16.2M 0.04%
116,832
+115,391
+8,008% +$14.8M
QGEN icon
284
Qiagen
QGEN
$8.54B
$16.2M 0.04%
274,319
-20,072
-7% -$1.15M
ISRG icon
285
Intuitive Surgical
ISRG
$127B
$16.1M 0.04%
44,779
+9,145
+26% +$3.15M
CTLT
286
DELISTED
CATALENT, INC.
CTLT
$16M 0.04%
125,041
+19,967
+19% +$2.57M
DTP
287
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
$16M 0.04%
311,552
+13,321
+4% +$669K
MTA
288
Metalla Royalty & Streaming
MTA
$688M
$15.9M 0.04%
2,295,476
-315,189
-12% -$2.32M
TAK icon
289
Takeda Pharmaceutical
TAK
$54.6B
$15.7M 0.04%
1,154,076
+281,425
+32% +$3.95M
NVG icon
290
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$15.7M 0.04%
876,797
-64,697
-7% -$1.13M
ECL icon
291
Ecolab
ECL
$78.1B
$15.7M 0.04%
66,886
+35,857
+116% +$8.1M
CVS icon
292
CVS Health
CVS
$133B
$15.7M 0.04%
152,024
-15,246
-9% -$1.41M
SO icon
293
Southern Company
SO
$109B
$15.4M 0.04%
223,953
+33,611
+18% +$2.14M
TEVA icon
294
Teva Pharmaceuticals
TEVA
$40.8B
$15.3M 0.04%
1,912,326
+305,004
+19% +$2.75M
NEX
295
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$15.2M 0.04%
4,283,608
-2,053,013
-32% -$8.6M
AGCO icon
296
AGCO
AGCO
$7.15B
$15.2M 0.04%
130,829
+2,267
+2% +$275K
GFLU
297
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
$15M 0.03%
172,792
+7,389
+4% +$660K
CNI icon
298
Canadian National Railway
CNI
$76.9B
$14.9M 0.03%
121,187
+4,349
+4% +$551K
RITM icon
299
Rithm Capital
RITM
$5.52B
$14.7M 0.03%
1,375,621
-53,902
-4% -$601K
MAA icon
300
Mid-America Apartment Communities
MAA
$15.4B
$14.7M 0.03%
64,097
+16,642
+35% +$3.44M

Similar funds

VanEck Associates's Q4 2021 Portfolio in Review

As of Q4 2021, VanEck Associates held 1,434 positions worth $43.2B, up 8.7% from $39.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

VanEck Associates's Q4 2021 filing shows 145 new, 810 increased, 388 reduced and 61 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 47,930 shares worth $99.5M. The largest sale was NVIDIA, an estimated $315M.

By sector, the portfolio is most concentrated in Materials at 36% of assets, down from 36% a quarter earlier, followed by Technology and Energy.

  • VanEck Associates's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 47,930 shares worth $99.5M.
  • VanEck Associates added most to Newmont in Q4 2021, an estimated $128M increase.
  • VanEck Associates's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $315M.
  • VanEck Associates fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $69.5M.
  • VanEck Associates's ten largest holdings make up 25% of its $43.2B portfolio in Q4 2021.
  • VanEck Associates opened 145 new positions and closed 61 in Q4 2021.
  • VanEck Associates's portfolio value rose 8.7% quarter-over-quarter to $43.2B.

Based on VanEck Associates's 13F filing for Q4 2021, filed 26 Jan 2022.